Traction News and Research

RSS

ThromboGenics, Alcon collaborate to commercialize ocriplasmin outside the US

ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, announces today that it has entered into an agreement with Alcon (a division of Novartis), the global leader in eyecare, for the commercialization of ocriplasmin in all markets outside the U.S.

16 Mar 2012

State abortion bills keep coming

Some call such legislation an "overreach," but at least some of the proposals are getting political traction, including a push in Washington State this week to require insurance plans to cover abortion.

12 Mar 2012

Stereotaxis fourth quarter net loss increases to $5.5M

Stereotaxis, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2011.

6 Mar 2012

Medicare, deficits and the politics of 2012

Reuters offers an analysis based on a recent poll and finds that people, shaken by the difficult economy, worry about the impact of efforts to address the nation's deficit. This concept could lead to Democrats finding traction for their positions on Medicare.

6 Feb 2012

Viewpoints: Komen takes a lashing; Is the safety net really intact?; Romney assails HHS' rule on contraception

With its roster of corporate sponsors and the pink ribbons that lend a halo to almost any kind of product you can think of, the Susan G. Komen for the Cure foundation has a longstanding reputation as a staunch protector of women's health. That reputation suffered a grievous, perhaps mortal, wound this week from the news that Komen, the world's largest breast cancer organization, decided to betray that mission.

5 Feb 2012

Thermo Fisher fourth quarter revenues increase 15% to $3.13B

Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2011.

From Thermo Fisher Scientific Inc. 1 Feb 2012

Haemonetics third quarter net income decreases 8% to $18.3M

Haemonetics Corporation today reported third quarter 2012 GAAP net revenue of $191.2 million, up 8%, net income of $18.3 million, down 8%, and diluted earnings per share of $0.72, down 7%.

31 Jan 2012

Angeion fourth quarter revenues increase 22% to $8.4 million

Angeion Corporation today reported financial results for its fourth quarter and fiscal year ended October 31, 2011.

16 Dec 2011

Reid threatens session through Christmas to finish business, including payroll tax cut and doc fix

Many insiders expect a final package will emerge that wraps the payroll tax cut extension into a broader bill that also includes other measures, like the Medicare physician payment fix, with end-of-year expiration dates.

8 Dec 2011

First Edition: December 7, 2011

In the news today, a status check on the work -- including the Medicare doc fix -- that Congress still needs to attend to before leaving Washington for the holidays.

7 Dec 2011

World Cell Race pulls 70 entries for title of world's fastest cell

A "team" of fast-moving, bone marrow stem cells from a research laboratory in Singapore has run away with the first World Cell Race, finishing first with a cellular speed record of 5.2 microns per minute (or 0.000204 inches per minute) in results announced today at the 51st Annual Meeting of the American Society for Cell Biology (ASCB).

3 Dec 2011

MergerTech launches $50M venture capital fund for healthcare IT

MergerTech Advisors is excited to announce the launch of 'MergerTech Capital', a new $50 million venture capital fund. The fund will focus on the investment and development of healthcare IT product and services firms, building on the sectors' substantial potential for extraordinary growth and creativity.

2 Dec 2011

Bovie Medical third quarter revenues decrease marginally to $6.3 million

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced its financial results for the third quarter and nine months ended September 30, 2011.

14 Nov 2011

New epigenetic therapy may treat recurrent metastatic NSCLC

Patients with recurrent metastatic non-small cell lung cancer have a morbid prognosis, but a new epigenetic therapy may have potential in this population, according to data published in Cancer Discovery, a journal of the American Association for Cancer Research.

10 Nov 2011

BioClinica third quarter service revenues increase 4.1% to $16.6 million

BioClinica, Inc., a global provider of clinical trial management and technology solutions, today announced its financial results for the third quarter and nine months ended September 30, 2011.

From Clario 9 Nov 2011

CompCare to distribute innovative lumbar traction DDS belt in the U.S., Canada and Puerto Rico

Comprehensive Care Corporation, which provides behavioral health, substance abuse and psychotropic pharmacy management services for managed care companies throughout the U.S., today announced that it has acquired exclusive distribution rights to an innovative patented product aimed directly at reducing depression in individuals resulting from chronic back pain.

24 Oct 2011

Republican rivals' attacks on 'Romneycare' gaining traction

GOP presidential hopeful Mitt Romney's health policies are not only the target of his Republican opponents but are also drawing attention and barbs from Democrats. Also on the trail, Newt Gingrich, another GOP primary candidate, criticized the tenor of the campaign season so far.

21 Oct 2011

First Edition: October 20, 2011

In today's headlines, reports analyzing the super committee's progress, and detailing how Republican rivals' stabs at 'Romneycare' are starting to gaining traction.

20 Oct 2011

Final ACO regs face last looks before public release

The final regulations to implement the accountable care organization provisions of the 2010 health care reform law have entered one of their last steps, according to an online notice. The Office of Management and Budget began its review of the final rule for the ACO program, also known as the Medicare Shared Savings Program, on Oct. 5. Such OMB reviews are usually the last or one of the last steps that regulations take before they are publicly issued.

12 Oct 2011

Progenra, Ono enter ubiquitin pathway research collaboration

Progenra, Inc. announced today that it has entered into a research collaboration with Ono Pharmaceutical Co., Ltd. Under the agreement, Progenra will collaborate with Ono to conduct assay development and high throughput screening by using Progenra's proprietary technology on multiple targets in the ubiquitin pathway.

11 Oct 2011